Nadine Chapman‐Rothe
Novartis (Switzerland)(CH)
Publications by Year
Research Areas
Urticaria and Related Conditions, Epigenetics and DNA Methylation, Dermatology and Skin Diseases, Coagulation, Bradykinin, Polyphosphates, and Angioedema, Mast cells and histamine
Most-Cited Works
- → Effect of omalizumab on angioedema in H 1 ‐antihistamine‐resistant chronic spontaneous urticaria patients: results from X‐ ACT , a randomized controlled trial(2016)128 cited
- → H1‐antihistamine‐refractory chronic spontaneous urticaria: it's worse than we thought – first results of the multicenter real‐life AWARE study(2017)122 cited
- → Increased efficacy of omalizumab in atopic dermatitis patients with wild‐type filaggrin status and higher serum levels of phosphatidylcholines(2013)110 cited
- → Chromatin H3K27me3/H3K4me3 histone marks define gene sets in high-grade serous ovarian cancer that distinguish malignant, tumour-sustaining and chemo-resistant ovarian tumour cells(2012)91 cited
- → Dual EZH2 and EHMT2 histone methyltransferase inhibition increases biological efficacy in breast cancer cells(2015)81 cited
- → Heterochromatinization induced by GAA-repeat hyperexpansion in Friedreich's ataxia can be reduced upon HDAC inhibition by vitamin B3(2013)78 cited
- → ATTENTUS, a German online survey of patients with chronic urticaria highlighting the burden of disease, unmet needs and real-life clinical practice(2015)78 cited
- → Antihistamine‐resistant chronic spontaneous urticaria: 1‐year data from the AWARE study(2018)76 cited
- → Antihistamine‐resistant chronic spontaneous urticaria remains undertreated: 2‐year data from the AWARE study(2020)65 cited
- → Omalizumab rapidly improves angioedema‐related quality of life in adult patients with chronic spontaneous urticaria: X‐ACT study data(2017)60 cited